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The purposeful application of fermentation in food and beverage preparation, as a means to provide palatability,
nutritional value, preservative, and medicinal properties, is an ancient practice. Fermented foods and beverages
continue to make a significant contribution to the overall patterns of traditional dietary practices. As our knowledge
of the human microbiome increases, including its connection to mental health (for example, anxiety and
depression), it is becoming increasingly clear that there are untold connections between our resident microbes and
many aspects of physiology. Of relevance to this research are new findings concerning the ways in which
fermentation alters dietary items pre-consumption, and in turn, the ways in which fermentation-enriched chemicals
(for example, lactoferrin, bioactive peptides) and newly formed phytochemicals (for example, unique flavonoids)
may act upon our own intestinal microbiota profile. Here, we argue that the consumption of fermented foods may
be particularly relevant to the emerging research linking traditional dietary practices and positive mental health. The
extent to which traditional dietary items may mitigate inflammation and oxidative stress may be controlled, at least
to some degree, by microbiota. It is our contention that properly controlled fermentation may often amplify the
specific nutrient and phytochemical content of foods, the ultimate value of which may associated with mental
health; furthermore, we also argue that the microbes (for example, Lactobacillus and Bifidobacteria species)
associated with fermented foods may also influence brain health via direct and indirect pathways.Introduction
‘The processes required for fermented foods were
present on earth when man appeared on the scene…
When we study these foods, we are in fact studying the
most intimate relationships between man, microbe
and foods.’ [1]
Prof. Keith H. Steinkraus, Cornell University, 1993
As highlighted in the quotation, our Paleolithic ancestors
had plenty of opportunity for the consumption of food
products (for example, honey, fruits or berries, and their
juices) that had been unknowingly subjected to natural
microbial fermentation. Without knowledge of microbes,
our ancestors recognized, over time, the palatability, pre-
servative, analgesic, and mentally stimulating or sedating* Correspondence: eselhub@partners.org
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reproduction in any medium, provided the orqualities of fermented foods and beverages [2]. Thus, the
stage was set for the purposeful application of fermentation
to provide value in the areas of human nutrition, traditional
medicine, and culture (ceremonies, and so on) [3,4]. It is
difficult to say with certainty when intentional fermentation
began in earnest; however, sophisticated measurements
of the chemical content within ancient Neolithic vessels
suggest intentional fermentation of fruit, rice, or honey
beverages has been in common practice for close to
10,000 years [5]. As agriculture expanded, so too did
intentional fermentation techniques. Beyond the clear
references to alcohol production, it is now obvious that
household and artisanal fermentation of cereals, dairy,
vegetables, fish, seafood and meats were a significant part
of ancestral dietary practices [6].
Modern advances in chemical preservation, refrigeration,
and transportation efficiency have not resulted in the
abandonment of fermented foods. At least in traditional
dietary practices, fermented foods and beverages remain
widespread, currently accounting for approximately one-
third of the human diet globally [7]. Moreover, as scientists
continue to uncover health-promoting properties ofLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diet, the traditional Japanese diet, and hunter-gatherer
diets), by extension there is a renewed examination of the
fermented foods that are so often a part of such ancient
diets [8]. Emerging research, as reviewed here, indicates
that fermentation may magnify the known benefits of a
wide variety of foods and herbs, influencing the bioavail-
ability and activity of the chemical constituents. In addition,
as our knowledge of the human microbiome increases
(the intestinal microbiota in particular), it is becoming
increasingly clear that there are untold connections be-
tween the ways in which microbes act upon dietary items
pre-consumption, and in turn, the ways in which these
fermented dietary items influence our own microbiota.
Here, we review and synthesize various lines of investi-
gation related to fermented foods, intestinal microbiota,
and mental outlook. We argue that the consumption of
fermented foods may be particularly relevant to the emer-
ging research linking traditional dietary practices and posi-
tive mental health. It is our contention that fermentation
may amplify the specific nutrient or phytonutrient content
of foods, the ultimate value of which is associated with
mental health; furthermore, we also argue that the
microbes associated with fermented foods may also
influence brain health via direct and indirect pathways.
Traditional diets and mental health
The shift away from traditional lifestyles has been linked
to increased rates of depression and other mental health
disorders [9-11]. Among the variables that might afford
protective or resiliency effects against mental health disor-
ders (depression in particular), diet has emerged as at least
one strong candidate [12]. Superficially, it would seem obvi-
ous, given the brain’s dependence upon nutrients for its
structure and function (including the micronutrients and
non-nutrient dietary antioxidants, for example polyphenols,
that run the antioxidant defense system) that nutrition
should be a target of research in mental health. Remarkably,
this area of research, now known as nutritional psychiatry,
is one that has been historically neglected or the subject of
poorly designed studies. However, there have been tremen-
dous strides in recent years and the research connecting
mental health and nutrition has become increasingly ro-
bust. Indeed, a recent 5-year prospective study (n = 23,020)
has shown that unhealthy maternal and early postnatal
dietary patterns (for example, processed and refined foods,
high-sugar beverages, high-sodium snacks) elevate the risk
of behavioral and emotional problems in children [13].
Traditional dietary practices, often exemplified by
Mediterranean and Japanese models, are typically charac-
terized by (relative to Western practices) higher intakes of
fruits and vegetables, fish and seafood, cereals with limited
processing, fiber, and only modest amounts of dairy and
lean meats [14]. A variety of population studies have linkedadherence to traditional dietary patterns with lowered risk
of anxiety or depression [15-20]. Among the more con-
vincing of these studies are the recent prospective inves-
tigations showing that stronger adherence to traditional
healthy dietary patterns is associated with a 25 to 30%
lower risk of depression [16,17]. Traditional Japanese
dietary practices, where fermented soy products are spe-
cifically linked to adherence, have also been associated
with lower rates of depressive symptoms [21,22]. Alcohol
has deservedly received much attention in the link
between problematic consumption and a higher risk
of depression. However, when consumed in modest
amounts (5 to 15 g per day) as part of traditional diet-
ary practices, alcohol (red wine in particular) has been
associated with a lower risk of depression [23]. Indeed,
light to moderate alcohol consumption has been asso-
ciated with lower systemic inflammation, a finding not
evident in those with depression [24].
Epidemiological studies show that there exists an ele-
vated risk of depressive symptoms in healthy adults with
blood chemistry indicative of insulin resistance [25].
Depressive symptoms correlate with higher fasting and
stimulated glucose levels, even in the absence of an associ-
ation with adiposity in adolescents at risk of type II diabetes
[26]. This is of relevance when viewed along with a rapidly
growing body of research highlighting the type-II-diabetes
protective properties of traditional dietary practices [27]. As
we will discuss, the intestinal microbiota, via a number of
mechanisms, may play a role in mediating the glycemic and
mood related effects of the Western dietary pattern [28].
Specific items within traditional dietary patterns have
been individually associated with protection against depres-
sion and, experimentally, these components have also
demonstrated antidepressant properties. Examples include,
but are not limited to soy foods, turmeric, cocoa, green tea,
coffee, blueberries, pomegranate, and honey. The isolated
polyphenols and other phytochemicals within these foods
have also been documented to provide antidepressive prop-
erties in experimental models [29-38]. In addition, specific
nutrients such as magnesium, zinc, vitamin C, folic acid, and
vitamin B12, have also been connected to resiliency against
depression or improvement in depressive symptoms [39-42].
The mechanisms by which required nutrients, such as
the aforementioned vitamins and minerals, influence
mood can be explained in part by their role in the produc-
tion of neurotransmitters [43]. However, the connection
between mood and non-essential dietary components
(for example, phytochemicals) has been the subject of
intense scrutiny; their role in the antioxidant defense sys-
tem as well as their ability to provide anti-inflammatory
support appears to be at play [44]. Advances in the under-
standing of the pathophysiology of mood and anxiety
disorders have provided a more complete picture of the
inducing role played by the tandem of oxidative stress
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inflammation (for example, cytokines, C-reactive protein),
and overwhelm of the normal antioxidant defense system,
are no longer dismissed as mere consequence in emotional
disorders [45]. The burden of oxidative stress and inflam-
mation is emerging as a viscous cycle that can directly in-
fluence mood, and the combination of the two appears to
be both a cause and a consequence of depression [46,47].
When levels of body-wide inflammatory cytokines are
elevated, they can subsequently signal the production of
inflammatory cytokines within the central nervous system
via microglia activation. Chronic activation of microglia
can compromise neuronal functioning by setting in mo-
tion a cascade of further inflammation and oxidative stress
[48]. The end result may manifest as compromised intra
and extracellular neuronal communication.
Inflammation and mood pathways
In this exciting area of research, one of the open questions
is how chronic inflammation might be initiated and main-
tained in illnesses such as depression, and what the gut has
to do with this. Emerging studies show that the normally
very selective intestinal barrier may be compromised in
depression (and in numerous conditions where depression
is often a hallmark symptom) [49-56]. Psychological stress
and exhaustive exercise have been shown to increase the
permeability of the intestinal barrier [57-59]. However,
a Westernized diet high in fat and sugar has also been
shown to cause a more porous intestinal lining, the conse-
quences of which include systemic access to food antigens,
environmental toxins, and structural components of
microbes, such as lipopolysaccharide endotoxin (LPS)
[60]. The latter agent, LPS, is particularly important regard-
ing depression; even relatively small elevations in systemic
LPS levels have been shown to provoke depressive symp-
toms and disturb blood glucose control [61-67]. Endotoxins
such as LPS can decrease the availability of tryptophan
and zinc, thereby negatively influencing neurotransmission
[68,69]. Moreover, systemic LPS can elevate inflammation
and oxidative stress. Traditional dietary practices have
completely divergent effects of blood LPS levels; signifi-
cant reductions (38%) have been noted after a one-month
adherence to a prudent (traditional) diet, while the
Western diet provokes LPS elevations [70]. These and
other findings help establish mechanisms whereby the
LPS-lowering, antioxidant, and anti-inflammatory proper-
ties of broad traditional dietary practices, as well as spe-
cific components within them, can help provide mood
support. Indeed, when the limitation of intestinal absorp-
tion is overcome, individual phenolic structures have been
shown, at least experimentally, to curb the breakdown of
central neurotransmitters, mimicking the proposed mech-
anistic properties of some primary antidepressant medica-
tions [71,72]. As we will discuss, enhanced bioavailabilityvia fermentation may therefore be an important factor in
food (or herbs) as medicine.
Microbiota and mental health
Related to the differences in traditional versus contempor-
ary Westernized dietary patterns and mental health is the
role of the intestinal microbiota. A decade ago, prior to the
scientific hypotheses of Logan et al. [73,74], the notion that
the intentional manipulation of the intestinal microbiota
could provide therapeutic value to human depressive and
fatigue states was, at the very least, outlandish. However, in
the ensuing years, many of the mechanisms first proposed
by Logan and colleagues (as listed, adapted from [73,74])
whereby beneficial microbes could influence mood or
fatigue, have been examined experimentally.
 Direct protection of the intestinal barrier;
 Influence on local and systemic antioxidant status,
reduction in lipid peroxidation;
 Direct, microbial-produced neurochemical production,
for example, gamma-aminobutyric acid (GABA);
 Indirect influence on neurotransmitter or
neuropeptide production;
 Prevention of stress-induced alterations to overall
intestinal microbiota;
 Direct activation of neural pathways between gut
and brain;
 Limitation of inflammatory cytokine production;
 Modulation of neurotrophic chemicals, including
brain-derived neurotrophic factor;
 Limitation of carbohydrate malabsorption;
 Improvement of nutritional status, for example,
omega-3 fatty acids, minerals, dietary
phytochemicals;
 Limitation of small intestinal bacterial overgrowth;
 Reduction of amine or uremic toxin burden;
 Limitation of gastric or intestinal pathogens
(for example, Helicobacter pylori);
 Analgesic properties.
Moreover, preliminary placebo-controlled human studies
have shown that oral probiotic microbes can decrease
anxiety, diminish perceptions of stress, and improve
mental outlook [75]. In the context of our later discussion
of fermented foods and their intersection with the gut-
brain-microbiota connection, a brief summary of this
microbiota-brain research is necessary. For interested
readers, more detailed reviews specific to the scientific
advances exploring direct and indirect relationships
between intestinal microbes and anxiety or depression
have recently been published [76,77].
Viewed strictly from the nutritional perspective, experi-
mental studies have shown that the administration of pro-
biotic bacteria to laboratory chow can increase peripheral
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turnover in the frontal cortex and limbic system [78].
In addition, probiotic-fortified laboratory chow increases
the tissue levels of omega-3 fatty acids [79], and the
omega-3 fatty acids play a critical role in communication
in and between nerve cells. The consumption of omega-3
fatty acids, eicosapentaenoic acid in particular, has been
linked to positive mental outlook and reduction in
mental distress in human beings [80]. Levels of other
anti-inflammatory fatty acids, such as gamma-linolenic
acid, also increase in the human plasma when co-
administered with probiotics [81]. It is also becoming
increasingly clear that the extent to which phytochemical
absorption can provide systemic antioxidant and anti-
inflammatory activity is controlled, at least to some degree,
by resident intestinal microbiota [82-84]. Finally, probiotics
and the overall profile of the intestinal microbiota can
influence tissue levels of mood-regulating minerals, such
as magnesium and zinc [85,86].
As mentioned, intestinal microbiota may also have
far-reaching effects related to glycemic control; our com-
mensal gut microbes may contribute to healthy glucose tol-
erance. Indeed, the oral administration of Bifidobacterium
lactis, and, in separate research, the combination of
Lactobacillus curvatus and Lactobacillus plantarum,
can improve fasting insulin levels and glucose turnover
rates, even in the presence of a high-fat diet [87,88].
Again, the minimization of the detrimental LPS burden
by beneficial microbes appears to be a central mechan-
ism in the promotion of normal glycemic control [89].
For example, bifidobacteria and other beneficial microbes
can prevent the efflux of LPS into systemic circulation,
while in human beings, the administration of probiotics
may diminish systemic access of gut-derived LPS and also
reduce reactivity to the endotoxin [90].
Beyond direct nutritional and glycemic effects, there
are other intriguing ways in which probiotics and the
intestinal microbiota have been connected to the brain.
When a strain of Lactobacillus rhamnosus is administered
to healthy animals under stress, there is a reduction in
anxiety and depression-like behaviors in experimental
models, such as the elevated plus maze and forced swim
tests. These behavioral changes were associated with alter-
ations in the GABA system of the brain in the probiotic
group, matching the known effects of antidepressant or
anxiolytic chemical agents (for example, anxiolytic agents
such as benzodiazepines work at GABA receptors) [91].
Importantly, the changes in behavior and brain chemis-
try were largely extinguished with vagotomy, suggesting
direct lines of communication from gut to brain [90].
Additional research shows that Lactobacillus helveticus
and Bifidobacterium longum added to animal drinking
water can increase nerve cell resiliency and reduce apop-
tosis during conditions of experimental physiological stress[92]. Moreover, oral Mycobacterium vaccae, a soil-based
microorganism widely distributed in nature, which can
easily find its way onto edible plants, has been shown in
experimental models to improve cognitive function and
diminish anxiety-like behavior among animals [93].
There are also a number of studies involving mice reared
in germ-free environments, the results of which seem to
demonstrate a direct role of intestinal microbiota on behav-
ior. Compared withconventional animals raised with the
normal range of intestinal microbiota, these animals display
the murine equivalent of what might be decreased anxiety
[94-96]. Meanwhile, supplementation with Bifidobacterium
appears to attenuate an exaggerated stress response and
maintain adequate levels of the neuropeptide brain-derived
neurotrophic factor (BDNF), levels of which are known to
be low in depression [97]. It is also noteworthy that even
mild chronic inflammation of the gastrointestinal tract can
provoke anxiety and diminish BDNF production in animals
[98]. Furthermore, supplementation with Bifidobacterium
also provides systemic protection against lipid peroxida-
tion and decreases brain monoamine oxidase activity,
thereby potentially increasing intersynaptic neurotrans-
mitter levels [99].
Rodent studies have provided compelling insights;
however, they have countless shortcomings as a reflection
of human microbiota, human dietary patterns, and the
ultimate intertwining of these variables with complex
mental health disorders. Far more convincing research,
albeit very preliminary at this juncture, comes from pub-
lished human studies involving probiotic administration.
The first formal investigation of a probiotic and human
mental outlook involved 132 otherwise healthy adults
consuming Lactobacillus casei fermented beverage for
three weeks; vs. placebo, significant improvement in mood
scores were noted upon the among those with the higher
baseline depressive symptoms [100]. A separate placebo-
controlled pilot study, one using the same Lactobacillus
casei probiotic (powder form), involved 39 chronic fatigue
syndrome patients. After two months, depression scores
remained unchanged between the groups, however Beck
Anxiety Inventory scores showed significant improvements
in anxiety versus placebo [101].
Michaël Messaoudi and colleagues from France evaluated
a Lactobacillus helveticus and Bifidobacterium longum
combination probiotic, which was orally administered
for one month (n = 55) in a placebo-controlled study
[102]. Among the otherwise healthy adults, significant
improvements in depression, anger, anxiety, and lower
levels of the stress hormone cortisol versus placebo
were noted. A concurrent experimental arm of the study
also confirmed that the probiotic added to the dietary of
rodents was effective in reducing behaviors indicative of
anxiety. Messaoudi’s group performed a secondary analysis,
looking specifically at those with the lowest baseline urinary
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showed improvement with Lactobacillus helveticus and
Bifidobacterium longum versus controls (particularly
in somatization, depression and anger-hostility), and
among this low cortisol sub-group the overall benefits
in anxiety and depression were pronounced over time
[103]. In addition, a study involving 44 patients with ir-
ritable bowel syndrome showed thatoral consumption
of a prebiotic fiber (trans-galactooligosaccharide) sig-
nificantly reduced anxiety in conjunction with marked
elevations in fecal bifidobacteria levels [104].
Finally, a small placebo-controlled study involving func-
tional magnetic resonance imaging (fMRI) has demon-
strated that the one-month consumption of a fermented
food containing Bifidobacterium animalis subsp lactis,
Streptococcus thermophilus, Lactobacillus bulgaricus, and
Lactococcus lactis subsp lactis can influence brain activity
versus baseline [105]. Specifically, the researchers reported
that the group who received the fermented dairy product,
versus unfermented counterpart and the no-intervention
controls, affected activity of brain regions that control
central processing of emotion and sensation. Enthusiasm
concerning this study runs high, with editorials in main-
stream journals claiming that this fMRI study, ‘provides
the first objective evidence that gut commensal and/or
probiotic bacteria influence brain activity in healthy
humans’,[106]. The study, of course, did not provide any
such objective evidence concerning ingested bacteria; it
was a study involving a transformed milk product, not
an isolated probiotic powder. Despite attempts to keep
caloric and macronutrient content equal, a fermented
milk product is not the same as an unfermented milk
product in only its microbiota. Within the study, there
was no evidence of a change in gut microbiota profile via
consumption of the fermented product; however, more im-
portantly, the fermentation of milk significantly alters bio-
active peptides and other chemicals that are well capable of
influencing central nervous system function [107-110]. In
short, objective evidence that ingested probiotic bacteria
alone (or diet-induced shifts in commensal bacteria) can
influence human brain activity has yet to be published.
Traditional diets and microbiota
Before proceeding to make the case for a more focused
investigation of fermented foods for mental health, it is
important to discuss the available research on traditional
dietary patterns and their ability to influence intestinal
microbiota. It is becoming increasingly clear that indi-
genous or traditional dietary patterns are directly inclu-
sive of many bacterium species that might be considered
to have probiotic potential. Indeed, it is estimated that
35% of all lactic acid bacteria isolated from raw fruits and
vegetables can survive gastric conditions [111]. The recent
study on the anti-anxiety effects of the soil microorganismMycobacterium vaccae in animals [93] suggests that we
would do well to broaden our considerations of the clas-
sically defined beneficial microbes, that is, beyond that of
exclusively the Lactobacilli and Bifidobacteria genera.
One of the first studies examining the effects of trad-
itional diet, 30 years ago, looked at differences in the fecal
microbiota of rural Japanese versus Canadian urbanites.
The researchers noted higher counts of Bifidobacterium
species and Lactobacilli in the rural Japanese, a group that
largely maintained a traditional high-fiber diet rich in
fermented foods, vegetables, and fish. The investigators
used culture technique to examine the microbiota, and
despite its limitations as a means to reflect the overall
intestinal microbiome, there were some interesting find-
ings. The amounts of Clostridia species in the Canadians
were higher, and overall there was greater biodiversity
(more genera and species) in the rural-dwelling Japanese
[112]. As discussed later, this has been the primary finding
of more sophisticated contemporary studies using DNA
sequencing of stool samples, that is, there is more bacterial
diversity in those consuming traditional diets. In follow-up,
this research group reported on the differences in fecal
microbiota among older adults residing in Tokyo versus
elderly rural Japanese maintaining a high-fiber traditional
diet inclusive of fermented foods. The results again showed
higher numbers of Bifidobacterium species among the
rural dwellers and lower amounts of Clostridium spe-
cies, Clostridium perfringens in particular [113].
Recent DNA techniques allow for a more broad evalu-
ation of the intestinal microbiome as mediated by diet.
Researchers have shown significant differences in the
fecal microbiota of Western European children versus
rural African children living in an environment resembling
that of our Neolithic ancestors. Overall, there were fewer
potentially pathogenic bacteria, and a far more diverse
range of microbes in rural Africans who maintain a
traditional lifestyle and consume traditional foods [114].
It is noteworthy that a variety of fermented foods are
consumed by those living in the rural African area
which was studied, and there are numerous lactic acid
bacteria present on plant foods within this traditional
diet [115]. Separate work has uncovered distinct differ-
ences in microbial groups and their functional genes
(for example, those governing metabolism of amino acids)
in US urban dwellers versus villagers living in Africa
and South America. Here again, the fecal microbiota of
US urbanites showed far less diversity than that of vil-
lagers in these distinct regions. Diet, rather than hygiene
per se, was reported to be the key spark for the develop-
ment of intestinal microbiota structure [116]. Remarkably,
investigations of highly preserved human coprolites
(ancient stool samples retrieved from archeological sites)
have demonstrated that their overall microbiome more
closely resembles that of modern humans living in
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porary urban dweller [117].
What then, are the broad implications of loss of micro-
bial diversity as a consequence of modernization? Detailed
dietary analysis in combination with DNA sequencing
of stool samples has its advantages. These techniques
have allowed researchers to determine that long-term
dietary patterns largely determine the main phyla of
the gut microbial profile [118]. However, psychological
stress or short-term dietary changes are capable of indu-
cing species-level changes to the intestinal microbiota
[119]. While the administration of singular or small
groups of select beneficial microbes may not have a
major impact on stable phyla, probiotic intervention
studies (as discussed previously) have taught us that
species-level application of microbes are not without
clinical relevance. A single strain of Lactobacillus, one
that might be carried with traditional foods, may improve
overall microbial diversity [120]. The administration of a
single Bifidobacterium strain, one among a genera com-
monly found in fermented dairy products, can increase the
intestinal quantity of completely separate Bifidobacterium
species, and Lactobacilli overall [121,122].
The potential of fermented foods
Thus far, we have highlighted that depression and other
mental health disorders are characterized by chronic,
low-grade inflammation and oxidative stress. Conversely,
a traditional diet rich in antioxidant, anti-inflammatory
foods may confer some level of protection against depres-
sion. We have also noted that an intestinal ‘inflammatory
microbiome’ appears to exist, one that may contribute to
altered mood via intestinal permeability, systemic LPS
burden, and even direct-to-brain microbe communication.
Such an inflammatory microbiome may be facilitated, at
least in part, by Western dietary habits. Research shows
that high-fat or high-sugar and low nutrient-value foods are
commonly consumed by those with depression, anxiety,
and high levels of chronic distress [123-125], thus contrib-
uting to the likelihood of an inflammatory microbiome.
Preliminary research in rodents and human beings suggests
that the behavioral consequences of an inflammatory
microbiome can be offset by the administration of beneficial
microbes. All this leads us full circle to the ancient Neolithic
vessels in asking to what extent fermented foods or bever-
ages might contribute to mental health. We are certainly
not the first to ask this question in the broad sense; in 1938,
Lloyd Arnold, MD, aptly a professor of both preventive
medicine and bacteriology at the University of Illinois, pon-
dered to what extent ancient diets, fermented foods, and
their effect on the ‘bacterial flora of the intra-intestinal con-
tents’ converged to promote health [126].
Today, scientific advances allow for some answers in
the direction toward the potential of fermented foods. Itis well established that with traditional dietary patterns,
fermentation can magnify protein quality [127] and the
bioavailabity of mood-regulating B vitamins, magnesium,
and zinc [128-131]. The effect of diet on intestinal
microbiota may also extend to vitamin D levels [132].
However, it is also becoming clear that the Lactobacillus
species isolated from traditional fermented foods are
biologically active in other ways, for example, upon oral
consumption, Lactobacillus plantarum strains isolated
from traditional Chinese fermented foods provide strong
antioxidant protection in animals [133]. Fermentation of
fruit and herbal smoothies with Lactobacillus plantarum
and other strains has been shown to preserve their poly-
phenolic compounds and vitamin C, and as expected, this
enhances subsequent free radical scavenging activity that
would otherwise be lost with storage [134]. Fermented
soymilk also has a more pronounced antioxidant capacity
than unfermented soymilk, and this activity is further
enhanced by the synergistic application of both lactic
acid bacteria and bifidobacteria together versus only
Lactobacilli or Bifidobacterium strains alone [135].
The fermentation of fiber-rich components of trad-
itional diets, such as, soy germ, wheat germ, rice bran,
or breads made via traditional fermentation techniques,
have been shown to produce novel bioactive compounds
capable of producing beneficial immune, glycemic, and
anti-inflammatory activities [136-139]. In the case of
fermented rice bran, where enhanced phenolic avail-
ability has been noted, there is specific experimental
evidence indicating beneficial mental properties via the
bioactive compounds. More specifically, compared with
controls, oral administration of fermented rice bran ex-
tract reduced experimental fatigue and stress [140,141].
Fermentation of rice bran, and other traditional foods,
such as mung beans, buckwheat sprouts, and lentils, is
known to increase the available GABA content signifi-
cantly [142-144]. Whereas synthetic GABA in oral form
has been classically dismissed as of limited benefit due
to absorption issues, research has reported value of the
oral administration of GABA derived from Lactobacillus
hilgardii fermentation in anxiety reduction in human
beings, and antidepressant activity via the administration
of GABA-rich red yeast rice [145,146].
Recent evidence suggests that the health-promoting
target of flavonoids is directed toward the human gut
bacterial metagenomes, and that these benefits have an
evolutionary origin. Functional analysis using clusters of
orthologous groups of bacteria target proteins suggests
that flavonoids regulate the metabolism of gut microbiota
[147]. Experimental research has shown that when com-
mon dietary polyphenols are subjected to fermentation,
the newly formed biotransformation phytochemicals are
more capable of causing a beneficial shift in microbial
growth stimulation [148]. In positioning fermented foods
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recent comparative research involving fermented and
non-fermented foods and herbal ingredients is worthy of
consideration. Researchers have examined the in vivo
properties of an herbal blend typically used in traditional
medicine to treat inflammatory disorders, comparing
its effects in the unfermented and fermented form. Blood
LPS levels were significantly lower when treated with the
fermented blend, as was C-reactive protein, a primary
marker of systemic inflammation. There was also a signifi-
cant reduction in LPS-induced intestinal permeability and
a significant rise in stool Lactobacillus species, neither of
which was noted with the unfermented blend [149].
Similar research has been documented with fermented
and unfermented herbs used for gastrointestinal disorders,
that is, more pronounced anti-inflammatory activity and
minimization of LPS-induced gene expression with the fer-
mented blend [150]. In separate work involving a singular
traditional food or medicinal agent, the anti-inflammatory
botanical Sophora flavescens, researchers, again using LPS
as the inducing agent, found a more pronounced anti-
inflammatory and antioxidant activity with the fermented
form [151]. Recently red wine has been shown to increase
Bifidobacterium levels, which in turn correlates with lower
serum LPS concentrations [152]. Fermented grape pomace
yields more total antioxidants and antioxidant activity than
its unfermented counterpart [153]. Remarkably, even
fermented fish oil, an agent with well-documented anti-
inflammatory and mood-support properties, has been
shown to provide an enhanced anti-inflammatory activity
versus its unfermented counterpart [154]. Given our previ-
ous discussions concerning LPS-induced inflammation, in-
testinal permeability and glycemic control, it should not be
surprising, perhaps, that fermented (versus unfermented)
dairy products can improve glucose metabolism and im-
prove antioxidant status in human beings [155,156].
The connection between fermented dairy products and
the growth of beneficial intestinal microbes has been well
described. However, the findings that (non-dairy) fermen-
ted foods and herbs can have a positive influence on the
intestinal microbiota are important in that there may be an
influence on longer-term gut-brain communication. For ex-
ample, isomalto-oligosaccharides are found in traditional
foods (for example, honey, sake, miso, and soy sauce) and
have been shown in animals and human beings to have a
beneficial effect in promoting the growth of Bifidobacteria
and Lactobacilli [157]. Providing just a few examples, fer-
mented (versus unfermented) burdock has been shown to
significantly promote the growth of bifidobacteria [158];
similar findings have been reported for fermented versus
unfermented soy [159]. The species-level microbiota within
local fermented foods is reflected in stool samples of the
human host [160]. When researchers make discoveries such
as that showing that a Lactobacillus pentosus strain derivedfrom fermented cabbage (kimchi) can improve mental
functioning and hippocampal BDNF production in animals
[161], the entire mosaic takes on greater meaning. It sug-
gests that we are only scratching the surface in our under-
standing of the relationship between potentially beneficial
food-derived microbes and brain health.
Conclusions
The purposeful application of fermentation for food
preservation, palatability, and other reasons is an ancient
art. Modern research is highlighting the potential value
of ancestral dietary practices on mental health, and on
resiliency against depression in particular. At the same
time, there has been tremendous progress toward better
understanding of the role played by the low-grade inflam-
mation and the intestinal microbiome in human health and
mental well-being [162,163]. Evidence would suggest that
the two major themes of these mostly separate highways of
research should converge; in other words, the fermented
foods so often included in traditional dietary practices have
the potential to influence brain health by virtue of the
microbial action that has been applied to the food or
beverage, and by the ways in which the fermented food
or beverage directly influences our own microbiota. This
could manifest, behaviorally, via magnified antioxidant
and anti-inflammatory activity, reduction of intestinal
permeability and the detrimental effects of LPS, im-
proved glycemic control, positive influence on nutritional
status (and therefore neurotransmission and neuropeptide
production), direct production of GABA, and other
bioactive chemicals, as well as a direct role in gut-to-
brain communication via a beneficial shift in the intestinal
microbiota itself.
In this discussion, we may unwittingly give the impres-
sion that fermentation is exclusively a beneficial applica-
tion to food and beverage production. Such is not the
case and not all forms of fermentation or fermented foods
can be painted with the same brush. For example, certain
microorganisms (for example, fungi) associated with
pickled foods may enhance the production of N-nitroso
compounds with potential carcinogenic properties [164].
Also, although agmatine and other polyamines found in
fermented meats, fish, and certain beverages have been
shown to have a variety of experimental benefits related
to brain health [165,166], a safe level of intake remains
unknown [165]. However, as outlined in our review,
there is more than ample justification to follow the
microbe-nutrition and gut-brain research pathways into
convergence. The clinical world of mental health involves
one where consumption of convenient, high-fat, or
high-sugar foods is the norm; these foods, at odds with
our evolutionary past, are not only undermining optimal
nutritional status, they have untold effects on the micro-
biome and ultimately the brain. Hopefully, further research
Selhub et al. Journal of Physiological Anthropology 2014, 33:2 Page 8 of 12
http://www.jphysiolanthropol.com/content/33/1/2will continue to illuminate the ways in which the clay fer-
mentation pots of our ancestors might be connected to the
emerging discipline of nutritional psychiatry.
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